BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15655547)

  • 1. The predictive value of p53, p53R2, and p21 for the effect of chemoradiation therapy on oesophageal squamous cell carcinoma.
    Okumura H; Natsugoe S; Matsumoto M; Mataki Y; Takatori H; Ishigami S; Takao S; Aikou T
    Br J Cancer; 2005 Jan; 92(2):284-9. PubMed ID: 15655547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of p53 and 14-3-3sigma for the effect of chemoradiation therapy on esophageal squamous cell carcinoma.
    Okumura H; Natsugoe S; Matsumoto M; Yokomakura N; Uchikado Y; Takatori H; Ishigami S; Takao S; Aikou T
    J Surg Oncol; 2005 Jul; 91(1):84-9. PubMed ID: 15999354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation Between Biomarker Candidate Proteins with the Effect of Neoadjuvant Chemoradiation Therapy on Esophageal Squamous Cell Carcinoma.
    Noda M; Okumura H; Uchikado Y; Omoto I; Sasaki K; Kita Y; Mori S; Owaki T; Arigami T; Uenosono Y; Nakajo A; Kijima Y; Ishigami S; Maemura K; Natsugoe S
    Ann Surg Oncol; 2018 Feb; 25(2):449-455. PubMed ID: 29188501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The predictive value of molecular markers (p53, EGFR, ATM, CHK2) in multimodally treated squamous cell carcinoma of the oesophagus.
    Sarbia M; Ott N; Pühringer-Oppermann F; Brücher BL
    Br J Cancer; 2007 Nov; 97(10):1404-8. PubMed ID: 17940507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement in radiosensitivity using small interfering RNA targeting p53R2 in esophageal squamous cell carcinoma.
    Yokomakura N; Natsugoe S; Okumura H; Ikeda R; Uchikado Y; Mataki Y; Takatori H; Matsumoto M; Owaki T; Ishigami S; Aikou T
    Oncol Rep; 2007 Sep; 18(3):561-7. PubMed ID: 17671702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and alteration of p53 and p21(waf1/cip1) influence the sensitivity of chemoradiation therapy for esophageal cancer.
    Shimoyama S; Konishi T; Kawahara M; Aoki F; Harada N; Shimizu S; Murakami T; Kaminishi M
    Hepatogastroenterology; 1998; 45(23):1497-504. PubMed ID: 9840093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nrf2 is useful for predicting the effect of chemoradiation therapy on esophageal squamous cell carcinoma.
    Kawasaki Y; Okumura H; Uchikado Y; Kita Y; Sasaki K; Owaki T; Ishigami S; Natsugoe S
    Ann Surg Oncol; 2014 Jul; 21(7):2347-52. PubMed ID: 24599410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-cycle regulators and the Ki-67 labeling index can predict the response to chemoradiotherapy and the survival of patients with locally advanced squamous cell carcinoma of the esophagus.
    Takeuchi H; Ozawa S; Ando N; Kitagawa Y; Ueda M; Kitajima M
    Ann Surg Oncol; 2003 Aug; 10(7):792-800. PubMed ID: 12900371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers for predicting the response of esophageal squamous cell carcinoma to neoadjuvant chemoradiation therapy.
    Okumura H; Uchikado Y; Setoyama T; Matsumoto M; Owaki T; Ishigami S; Natsugoe S
    Surg Today; 2014 Mar; 44(3):421-8. PubMed ID: 23605218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of response to chemo-radiotherapy and radiotherapy for esophageal squamous cell carcinoma.
    Miyazaki T; Kato H; Faried A; Sohda M; Nakajima M; Fukai Y; Masuda N; Manda R; Fukuchi M; Ojima H; Tsukada K; Kuwano H
    Anticancer Res; 2005; 25(4):2749-55. PubMed ID: 16080521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between high FBXW7 expression in pretreatment biopsy specimens and good response to chemoradiation therapy in patients with locally advanced esophageal cancer: A retrospective study.
    Gombodorj N; Yokobori T; Tanaka N; Suzuki S; Kuriyama K; Kumakura Y; Yoshida T; Sakai M; Sohda M; Baatar S; Miyazaki T; Nishiyama M; Shirabe K; Kuwano H
    J Surg Oncol; 2018 Jul; 118(1):101-108. PubMed ID: 30098297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of p53R2 is related to prognosis in patients with esophageal squamous cell carcinoma.
    Okumura H; Natsugoe S; Yokomakura N; Kita Y; Matsumoto M; Uchikado Y; Setoyama T; Owaki T; Ishigami S; Aikou T
    Clin Cancer Res; 2006 Jun; 12(12):3740-5. PubMed ID: 16778101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 Mutation status predicts pathological response to chemoradiotherapy in locally advanced esophageal cancer.
    Makino T; Yamasaki M; Miyata H; Yoshioka S; Takiguchi S; Fujiwara Y; Nakajima K; Nishida T; Mori M; Doki Y
    Ann Surg Oncol; 2010 Mar; 17(3):804-11. PubMed ID: 19885698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of the response to chemoradiation and prognosis in oesophageal squamous cancer.
    Kishi K; Doki Y; Miyata H; Yano M; Yasuda T; Monden M
    Br J Surg; 2002 May; 89(5):597-603. PubMed ID: 11972550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 Protein accumulation as a prognostic marker of preoperative radiotherapy and/or chemotherapy in advanced squamous cell esophageal carcinoma--preliminary report.
    Nasierowska-Guttmejer A; Szawłowski A; Jastrzebska M; Jeziorski K; Radziszewski J
    Dis Esophagus; 1999; 12(2):128-31. PubMed ID: 10466045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of TP53 transcriptional activity on p21 and bax in patients with esophageal squamous cell carcinomas treated by definitive chemoradiotherapy.
    Michel P; Magois K; Robert V; Chiron A; Lepessot F; Bodenant C; Roque I; Seng SK; Frebourg T; Paillot B
    Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):379-85. PubMed ID: 12243811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The telomere/telomerase binding factor PinX1 is a new target to improve the radiotherapy effect of oesophageal squamous cell carcinomas.
    Qian D; Zhang B; He LR; Cai MY; Mai SJ; Liao YJ; Liu YH; Lin MC; Bian XW; Zeng YX; Huang JJ; Kung HF; Xie D
    J Pathol; 2013 Apr; 229(5):765-74. PubMed ID: 23341363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of Aurora-A expression with the effect of chemoradiation therapy on esophageal squamous cell carcinoma.
    Tamotsu K; Okumura H; Uchikado Y; Kita Y; Sasaki K; Omoto I; Owaki T; Arigami T; Uenosono Y; Nakajo A; Kijima Y; Ishigami S; Natsugoe S
    BMC Cancer; 2015 Apr; 15():323. PubMed ID: 25924824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yield of p53 expression in esophageal squamous cell cancer and its relationship with survival.
    Sankalecha TH; Gupta SJ; Gaikwad NR; Shirole NU; Kothari HG
    Saudi J Gastroenterol; 2017; 23(5):281-286. PubMed ID: 28937022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of p53 protein expression with responses and survival of patients with locally advanced esophageal carcinoma treated with chemoradiotherapy.
    Muro K; Ohtsu A; Boku N; Chin K; Oda Y; Fujii T; Hosokawa K; Yoshida S; Hasebe T
    Jpn J Clin Oncol; 1996 Apr; 26(2):65-9. PubMed ID: 8609696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.